The New York State Medical Marijuana Program updated its website today and revealed that it will be registering five more organizations. The program’s initial licenses were awarded to Bloomfield...
Earlier this week, we highlighted a story published on Leafly regarding lobbying efforts by GW Pharma (NASDAQ: GWPH). Leafly’s Bruce Barcott discovered that GW Pharma and its U.S. subsidiary,...
After a boom in the stock prices of Canadian licensed producers (LPs) in 2016 that left the average stock up more than 355%, the sector is performing very well...
ETF Managers Group, based in Summit, New Jersey, has filed an initial registration statement for what could be the first cannabis exchange-traded fund (ETF), the Emerging AgroSphere ETF. The...
Executives at many publicly-traded cannabis companies have been selling stock aggressively since the market rally began in September. We had previously reported substantial insider activity at General Cannabis (OTC:...
Most cannabis investors are familiar with the bull market in Canadian licensed producers (LPs), with 2016 performance of better than 200% gains in each of the publicly-traded companies for...
One of the cannabis industry’s most successful entrepreneurs, Mike “BigMike” Straumietis, the founder and CEO of Advanced Nutrients, was planning a huge Super Bowl party, but, facing pressure from...
The South by Southwest (SXSW) Conference & Festivals, a major gathering in Austin, TX that will celebrate its 31st anniversary this year, is known for allowing attendees to discover the...
ScottsMiracle-Gro (NYSE: SMG) reported its FY17-Q1 results for the quarter ending 12/31/16 on January 31st, with sales of $247mm in what is a seasonally slow quarter rising 27%. Driving the...
Investing in the cannabis industry continues to become more mainstream, with interest gathering even among investment professionals. The CFA Society San Francisco will be hosting “The Business of Bud:...
We wrote last week about The Canadian Bioceutical Corporation (CSE: BCC) (OTC: CBICF) acquiring Arizona cannabis operations and an option to acquire a Nevada licensed cultivator for $25mm USD, with $15mm...
We have written previously about the rampant insider selling at cannabis companies in general and at Cannabis Sativa (OTC: CBDS) in particular. While it’s not his first sale, CBDS...
This post is a reprint of one of the three feature articles from the January edition of the 420 Investor Newsletter, which was published on 12/31 and distributed to...
In yet another example of publicly-traded Canadian companies entering the U.S. cannabis industry, Canadian Bioceuticals (CSE: BCC) (OTC: CBICF), through its CGX Life Sciences subsidiary, announced today the acquisition...
Following up on its September initiation of coverage of the cannabis industry, Cowen and Company has extended its coverage to Canada in a report entitled “O Cannabis! – Initiating...
Cannabis stocks are hot, with trading volumes remaining strong into 2017 after a 88% rise in the Cannabis Stock Index last year, with all of the gains coming after...
Investment Bank Cowen and Company, which initiated coverage on the cannabis industry in September, is hosting a gathering of institutional investors in New York City on January 12th. Several...
Just one year after announcing an alliance with New Frontier, Arcview Market Research revealed that it will now be working with BDS Analytics to create its 5th Edition of The State...
Building a cannabis empire in the United States is no easy task given the many obstacles created by federal illegality of the plant. Access to banking, an inability to scale operations...
Early trading in CanniMed Therapeutics (TSX: CMED) was disappointing, as the recent IPO broke its $12 offering price and traded below the $11.28 underwriters price. In the first half-hour...
Perhaps the biggest story of 2016 in the cannabis capital markets was the surge in prices and the amount of capital raised for the cannabis industry in Canada during...
Canabo Medical (TSXV: CMM) (OTC: CAMDF) announced that it has closed its $8.4 financing with Aphria (TSXV: APH) (OTC: APHQF), selling the licensed producer 6mm shares at $1.40 in...
As Canadian licensed producers have prepared to add capacity in conjunction with the transition ahead from a medical cannabis program solely to a broader legalized cannabis environment likely to...
CanniMed Therapeutics (TSX: CMED) priced its initial public offering at $12, selling 5mm shares through a syndicate led by AltaCorp Capital to raise $60mm. The underwriters, which also included Canaccord...
With little fanfare, the world’s first cannabis mutual fund launched earlier this year, and it has failed miserably to date, with investors actually losing money during a major bull...
